We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-2.00 | -0.15% | 1,333.00 | 1,333.00 | 1,334.00 | 1,337.50 | 1,333.00 | 1,335.00 | 350,415 | 09:20:46 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1889 | 11.22 | 55.34B |
Date | Subject | Author | Discuss |
---|---|---|---|
09/4/2022 07:44 | Thanks, abdullla! You have a good memory and good maths skills! If I sell my entire collection of GSK shares at 2012p, it should bring back £1m. .......;0) | tradermichael | |
08/4/2022 23:02 | I'm retaining both holdings after the demerger. | patientcapital | |
08/4/2022 19:37 | I plan to exit my GSK positions the month before. | alphorn | |
08/4/2022 18:04 | TM thanks for the info,good luck to the long holding players,from memory I think you are going to be a Millionaire on your GSK sell by date !!! | abdullla | |
08/4/2022 16:24 | abdullla - the 'split' (demerger and listing of Haleon) is expected to take place in July 2022. I plan to continue to watch the price evolution in the 6 weeks run up to the event and ideally sell at a nice profit before then .... ;0) | tradermichael | |
08/4/2022 15:56 | TM when is the SPLIT and when will you sell? before or after the event ,please give some dates,thanks | abdullla | |
08/4/2022 15:34 | There is old adage with shares (does anyone know if its still true): Sell in May and go away | netcurtains | |
08/4/2022 15:29 | Its an individual decision, based on your purchase cost! However, its made a steady rise from 1484p exactly one month ago. Can't believe that, after a long time, 8 out of 10 of my GSK holdings are currently in profit, just as the dividend is being reduced. Tempted to sell as I'm reluctant to get caught up with the 'split', but for me (for now) its a HOLD ..... ;0) | tradermichael | |
08/4/2022 14:48 | What's the recommendation at this price, hold or sell? | newbie100 | |
08/4/2022 14:37 | Good on ya Emma | pcok | |
08/4/2022 07:24 | New high for the last year. At least we weren't saddled with Unilever paper! | patientcapital | |
07/4/2022 19:31 | IG account divi payment the next day....then another couple of days to clear | mashup001 | |
07/4/2022 15:29 | Interactive Investor posted divi on opening, as usual. Barclays always a day late. | jonjoneil | |
07/4/2022 10:38 | Whoa...wonders will never cease, divi in Halifax already, this must be a first. :-)) | andyadvfn1 | |
07/4/2022 09:51 | 23p/share dividend in my AJ Bell accounts this morning, ready for more GSK shares ..... ;0) | tradermichael | |
06/4/2022 17:35 | GlaxoSmithKline suspends shipments of supplements, vitamins to Russia GlaxoSmithKline (NYSE:GSK) said that its consumer healthcare unit has stopped importing food supplements and vitamins to Russia in the wake of the country's invasion of Ukraine. Drugs and essential medical supplies will still be provided to Russia. GSK (GSK) has previously said it has stopped all advertising in Russia and has stopped entering into contracts with the Russian government or military You what? Prior contracts with Russian military? | geckotheglorious | |
06/4/2022 16:58 | So no one fell for Buywell's April Fools post | estienne | |
06/4/2022 15:36 | News Highlights: Top Company News of the Day 06 April 2022 - 04:30PM Dow Jones News Glaxo to Curb Drugstore Staples in Russia as It Walks Ethical Tightrope The drugmaker is to cut nearly a third of its consumer healthcare products in Russia as executives across the pharmaceutical industry grapple with an ethical dilemma over their response to the war in Ukraine. | misca2 | |
06/4/2022 15:19 | broke thru 1707p resistence needs confirming Friday Eve | misca2 | |
06/4/2022 15:00 | GlaxoSmithKline Plc said a study it conducted showed people age 50 or older in the U.S. who have had Covid-19 may be at greater risk of developing shingles compared with those who haven't been diagnosed with Covid-19. The company said that in this retrospective cohort study, people aged 50 or older who contracted Covid-19 were 15% more likely to develop shingles compared with controls who were never diagnosed with Covid-19. The risk of shingles was elevated for up to six months after a Covid-19 diagnosis. People hospitalized for Covid-19 were 21% more likely to develop shingles. The study observed adults aged 50 years and older using claims data from two large U.S. databases and matched persons with and without Covid-19 using various known shingles risk factors. Anyone vaccinated against either shingles or Covid-19 was excluded from the cohorts. Glaxo said the results highlight the importance of preventative measures, such as vaccination, to protect the health and wellbeing of older adults who are at risk for vaccine-preventable diseases like Covid-19 and shingles. Shingles, also known as herpes zoster, is caused by a reactivation of the varicella zoster virus--the same virus that causes chickenpox--which lays dormant in the body after the initial infection. Nearly all adults over age 50 carry the virus that causes shingles. Natural age-related decline of the immune system can allow VZV to resurface, causing shingles. People with a suppressed or compromised immune system also are at increased risk of developing shingles. The study authors, as well as case report publications, suggest that Covid-19 could trigger shingles by disrupting immune cells, allowing VZV to reactivate. Glaxo said more research is needed to confirm this hypothesis. Write to Chris Wack at chris.wack@wsj.com (END) Dow Jones Newswires April 06, 2022 10:37 ET (14:37 GMT) | misca2 | |
05/4/2022 17:24 | Cheap even. | patientcapital | |
05/4/2022 14:23 | Not obvious - tax year-end??? Bit of forex movement too. | alphorn | |
05/4/2022 14:20 | There is a left shoulder, but the line climbed to 1600p, rather than dropping to form a shoulder. So, its not looking like a classic inv H&S, I think. Damn good rise though and I'm hoping to see a breakout above 1700p soon.... ;0) | tradermichael | |
05/4/2022 14:09 | AZN moving up too. | alphorn |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions